# A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

Source: https://onco.cc/trials/nct06010342/  
OnCo record `nct06010342` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of TL118 Capsule in advanced solid tumours, run by Teligene US, now recruiting.

## Summary

A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients is a phase 2 interventional study registered as NCT06010342 by Teligene US, with 60 participants planned, started 2023-03-16 and due to reach its primary completion in 2027-12. Interventions recorded: TL118 Capsule.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06010342
- Phase: 2
- Setting: A Phase 2 Study of TL118 for the Treatment of Patients With Solid Tumors Harboring NTRK Gene Fusions
- Sponsor: Teligene US
- Enrolled: 60

## Sources

- ClinicalTrials.gov NCT06010342: https://clinicaltrials.gov/study/NCT06010342

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct06010342.json